Qingdao Vland Biotech INC. (603739.SS)
- Previous Close
10.42 - Open
10.43 - Bid 11.46 x --
- Ask --
- Day's Range
10.01 - 11.46 - 52 Week Range
7.70 - 18.26 - Volume
8,056,540 - Avg. Volume
5,157,935 - Market Cap (intraday)
2.9B - Beta (5Y Monthly) 0.02
- PE Ratio (TTM)
42.44 - EPS (TTM)
0.27 - Earnings Date --
- Forward Dividend & Yield 0.10 (0.96%)
- Ex-Dividend Date May 31, 2023
- 1y Target Est
--
Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was incorporated in 2005 and is headquartered in Qingdao, China.
www.vlandgroup.comRelated News
Performance Overview: 603739.SS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603739.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603739.SS
Valuation Measures
Market Cap
2.64B
Enterprise Value
2.82B
Trailing P/E
38.59
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.25
Price/Book (mrq)
1.56
Enterprise Value/Revenue
2.32
Enterprise Value/EBITDA
23.98
Financial Highlights
Profitability and Income Statement
Profit Margin
5.85%
Return on Assets (ttm)
1.97%
Return on Equity (ttm)
5.07%
Revenue (ttm)
1.21B
Net Income Avi to Common (ttm)
70.95M
Diluted EPS (ttm)
0.27
Balance Sheet and Cash Flow
Total Cash (mrq)
547.52M
Total Debt/Equity (mrq)
40.27%
Levered Free Cash Flow (ttm)
32.6M
Company Insights: 603739.SS
603739.SS does not have Company Insights